Salute e Benessere

Photocure ASA: Results for the third quarter of 2023

Photocure reported total group revenues of NOK 107.5 million in the third quarter of 2023 (NOK 106.8 million), and an EBITDA* of NOK 3.3 million (NOK 4.7 million), driven by a combination of price increases and a benefit from foreign exchange, partially offset by lower unit volumes in the U.S. The Hexvix®/Cysview® revenues ended at NOK 107.3 million in the quarter (Q3 2022: NOK 96.9 million). The EBIT was NOK -3.9 million (NOK -1.4 million). In the prior-year period, Photocure received a NOK 9.3…
PR Newswire
08/11/2023

SKF strengthens magnetic bearings offer by acquiring fibre composite company

Frédéric Ponson, Director, SKF Magnetic Bearings, says: "This acquisition will help us to further grow and develop our magnetic bearings business. 2C Composites has developed a leading and unique technology of composite layers that, besides strengthening our magnetic bearings offer to existing customers, also has the potential to grow the business with additional promising revenue streams." Frédéric Ponson, Director, SKF Magnetic Bearings, says: "This acquisition will help us to…
PR Newswire
08/11/2023

Retirement Home Service Market to Reach $14.2 billion Globally, by 2032 at 4.2%…

Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/75138 Request The Sample PDF Of This Report:https://www.alliedmarketresearch.com/request-sample/75138 Retirement home service typically include meals, accommodation, housekeeping, social activities, and more. It offers an array of benefits including safety & security, social engagement, healthcare practices, nutritious meals etc. Prime determinants of growth The growth of the...
PR Newswire
08/11/2023

ANNUAL REPORT 2022/23 (EARNINGS RELEASE)

For the full 2022/23 financial year, Ambu reported 7.6% organic revenue growth. This was driven by Endoscope Solutions posting 15% organic growth, the main drivers being urology and ENT growing high double-digits, as well as pulmonology contributing positively, with a strengthened offering. As a result of Ambu's focused execution, the company delivered an EBIT margin of 6.3%, mainly driven by revenue growth and reduced operational costs in distribution and staff, as well as a positive free...
Nasdaq GlobeNewswire
08/11/2023

AMBU ANNOUNCES FINANCIAL OUTLOOK FOR THE 2023/24 FINANCIAL YEAR

/24. Also, today, Ambu will publish its Q4 and full-year earnings release along with its Annual Report, including the company's Sustainability Report, and its Remuneration Report and Corporate Governance Report for 2022/23. MARKET CONDITIONSDuring 2022/23, Ambu witnessed increased geopolitical uncertainty and a volatile macroenvironment, affecting the global economy and resulting in inflationary effects on raw materials, energy prices and logistics costs. This is a tendency that the...
Nasdaq GlobeNewswire
08/11/2023

Addex Regains Nasdaq Listing Compliance

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, November 8, 2023 - Addex Therapeutics(SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced it had received written notification from The Nasdaq Stock Market LLC (Nasdaq) that it has regained compliance with the minimum bid price requirement of $1.00 per ADS under Nasdaq Listing Rule 5550(a)(2) and currently meets all other...
Nasdaq GlobeNewswire
08/11/2023

Ultimovacs ASA Reports Third Quarter 2023 Financial Results and Provides General…

Oslo, November 8, 2023:Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, announces its third quarter 2023 results today. “The recent months have allowed us to further advance the clinical development of our universal therapeutic cancer vaccine, UV1. The first data from a randomized Phase II study reported that UV1 showed a clinically meaningful survival benefit in cancer patients suffering from malignant...
Nasdaq GlobeNewswire
08/11/2023

Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic…

Yacoub Amin, CEO of Wiik Pharma said, "This commercial partnership with Telix marks a major step towards achieving Wiik Pharma's vision to improve the diagnosis and treatment management of patients with difficult-to-detect and treatment-requiring diseases. We have high expectations for the collaboration with Telix, not just for Illuccix but also for other upcoming diagnostics and therapeutics in their investigational pipeline." Yacoub Amin, CEO of Wiik Pharma said, "This…
PR Newswire
08/11/2023

Nonwoven Filter Media Market to Reach $13.7 Billion, Globally, by 2032 at 6.5%…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/517 Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/517 Prime determinants of growth The global Nonwoven filter media market is experiencing growth due to several factors such as increase in demand for water filtration and growth in HVAC systems as HVAC systems utilize nonwoven filter media to capture airborne particulates, allergens, and...
PR Newswire
07/11/2023

Cleanroom Disposable Gloves Market to Reach $4.6 Billion, Globally, by 2032 at…

Prime determinants of growth Prime determinants of growth Surge in demand for cleanroom disposable gloves from electronics industry is boosting the cleanroom disposable gloves market growth. However, the high cost associated with cleanroom disposable gloves is expected to act as a major restraint for market growth. Nevertheless, technological advancements are anticipated to offer many opportunities for market growth in the coming years. Download Sample Pages of Research Overview: ...
PR Newswire
07/11/2023

Fabrics for Sun Protection Market to Reach $23.1 Billion, Globally, by 2032 at…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/245788 Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/245788 Prime determinants of growth The global Fabrics for Sun Protection market is driven by the surge in skin health awareness. However, high cost associated with Fabrics for Sun Protection production is anticipated to hinder the growth of the market. Nevertheless, surge in demand for...
PR Newswire
07/11/2023

Vitiligo Market Growth to Undergo Significant Changes by 2032, Predicts…

Key Takeaways from the Vitiligo Market Report Key Takeaways from the Vitiligo Market Report Discover which therapies are expected to grab the major vitiligo market share @Vitiligo Market Report Vitiligo Overview Vitiligo is a frequently occurring skin condition characterized by well-defined white patches resulting from the loss of melanocytes in the epidermis. It is often linked to autoimmune disorders, with thyroid issues being the most common. While the precise cause of...
PR Newswire
07/11/2023

Nyxoah to Participate in the Jefferies London Healthcare Conference

Nyxoah to Participate in the Jefferies London Healthcare ConferenceMont-Saint-Guibert, Belgium – November 7, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Jefferies London Healthcare Conference, which takes place November 14 – 16, 2023 in…
Nasdaq GlobeNewswire
07/11/2023

NANOBIOTIX Announces Closing of Global Offering

PARIS and CAMBRIDGE, Mass., Nov.07, 2023(GLOBE NEWSWIRE) --NANOBIOTIX(Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the closing today (the “ Closing ”) of its global follow-on offering reserved to specified categories of investors, including after partial exercise by the underwriters of their option to purchase...
Nasdaq GlobeNewswire
07/11/2023

Alkermes to Participate in the Jefferies London Healthcare Conference

Alkermes Contact: Jamie ConstantineInvestor Relations+1 781 873 2402 Alkermes Contact: Jamie ConstantineInvestor Relations +1 781 873 2402 Logo -https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg View original content: https://www.prnewswire.co.uk/news-releases/alkermes-to-participate-in-the-jefferies-london-healthcare-conference-301980666.html
PR Newswire
07/11/2023

Q1 2023/24 - Lower revenue in a challenging market

ANNOUNCEMENT NO. 247 Trading statement for Q1 2023/24 (1 July - 30 September 2023) Lower revenue in a challenging marketRevenue for the first quarter of 2023/24 was, as expected, affected by continuing challenging market conditions, declining 20% to DKK 91.1 million from DKK 113.8 million in the year-earlier period. The lower revenue was mainly due to a 50% drop in sales of instruments. EBITDA fell to DKK 41.5 million in the first quarter from DKK 65.2 million in the same...
Nasdaq GlobeNewswire
07/11/2023

Professional Hand Hygiene Market to Hit $8.18 Billion by 2028, Emergence of…

Browse in-depth TOC on "Professional Hand Hygiene Market" Browse in-depth TOC on "Professional Hand Hygiene Market" 110 – Tables 92 – Figures 306 – Pages Professional Hand Hygiene Market Report Scope Get 10% Free Customization Worth$1500 :https://www.arizton.com/customize-report/4015 The expansion of the hospitality and healthcare industries has led to heightened consumption of hand hygiene products. For instance, the US, the...
PR Newswire
07/11/2023

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing…

Under the Sub-Licensing agreement, SciClone will pursue the development and registration of ORSERDU in China and commercialise ORSERDU upon its regulatory approval in China. Under the Sub-Licensing agreement, SciClone will pursue the development and registration of ORSERDU inChinaand commercialise ORSERDU upon its regulatory approval inChina. "Patients living with metastatic breast cancer need effective and tolerable options," saidElcin Barker Ergun, CEO of the Menarini Group...
PR Newswire
07/11/2023

Deputy Chief Executive Officer's appointment

Press release Ecully, November 7, 2023 – 6.00 p.m. Appointment of Sandrine Carleas Deputy Chief Executive OfficerThe Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, announces the appointment ofSandrine Carleas Deputy Chief Executive Officer. Ms. Carle joined Spineway in July 2022, at the time of the acquisition of Spine Innovations, where she was CEO. She was instrumental in the successful integration of Spine...
Nasdaq GlobeNewswire
07/11/2023

Monthly information related to total number of voting rights and shares…

Article 223-16 of general regulation of French Autorité des Marchés FinanciersListing markets:Euronext Paris from Euronext (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) &Nasdaq Global Select Market in the United-States (Symbol: PHXM) Website : www.phaxiam.com DateTotal of shares composing the share capitalTotal of brut(1)voting rightsTotal of net(2)voting rights January 31, 202331 018 55332 514 77132 512 271...
Nasdaq GlobeNewswire
07/11/2023

IPSEN - Buy-back programme - Art 5 of MAR - Week 44 - 2023

Statement of transactions in own shares from October 30 to November 03, 2023 BNP PARIBAS Aggregated presentation by day and by market Name of issuerIdentification code of issuer (Legal Entity Identifier)Day of transaction...
Nasdaq GlobeNewswire
07/11/2023

Eurobio Scientific: CATHERINE COURBOILLET TO JOIN EUROBIO SCIENTIFIC BOARD AS AN…

CATHERINE COURBOILLET TO JOIN EUROBIO SCIENTIFIC BOARD AS AN INDEPENDENT MEMBERParis, November 7, 2023, 5:40 pm Eurobio Scientific(FR0013240934, ALERS), (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro specialty medical diagnostics and life sciences, today announces Ms Catherine Courboillet has agreed to join the Board of Directors. A resolution relating to her appointment will be included on the agenda of the next general shareholder meeting in June 2024...
Nasdaq GlobeNewswire
07/11/2023

Genmab Announces Financial Results for the First Nine Months of 2023

November 7, 2023 Copenhagen, Denmark;Interim Report for the First Nine Months Ended September 30, 2023Highlights Epcoritamab (TEPKINLY ® ) was granted conditional marketing authorization by the European Commission (EC) to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapyEpcoritamab (EPKINLY ™ ) was approved by the Japan Ministry of Health, Labour and Welfare to treat adults with certain types of...
Nasdaq GlobeNewswire
07/11/2023

Veterinary Vaccines Market size worth $ 13.33 Billion, Globally, by 2028 at…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=31751 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=31751 Browse in-depth TOCon" Veterinary Vaccines Market " 202 - Pages 126 – Tables 37 – Figures Veterinary Vaccines Market: A Pillar of Animal Health and Productivity In a world w here animal well-being is paramount, the Veterinary Vaccines Market stands as a beacon of preventive healthcare for...
PR Newswire
07/11/2023
Altri  Comunicati